Who Owns ATHE?

Alterity Therapeutics Limited — Institutional Ownership & 13F Holdings

$4.70

+0.07 (+1.62%)

Market Cap

$32.2M

Shares Outstanding

16,941,100

Institutional Holders

11

Total Inst. Value

$832K

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

2

Closed Positions

3

Increased

5

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Point72 Asset Management, L.P.$453K131,431
2MORGAN STANLEY$150K43,701
3HB Wealth Management, LLC$129K37,483
4UBS Group AG$45K13,004
5BNP PARIBAS FINANCIAL MARKETS$33K9,752
6Twin Lakes Capital Management, LLC$20K5,925
7OSAIC HOLDINGS, INC.$626181
8RHUMBLINE ADVISERSNew$450130
9Blue Trust, Inc.$13840
10Steward Partners Investment Advisory, LLC$216

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-700$150K

Related Stocks

Frequently Asked Questions

How many institutional investors hold ATHE?

As of Q1 2025, 11 institutional investors report holding ATHE (Alterity Therapeutics Limited) in their 13F filings.

Which hedge fund owns the most ATHE?

The largest institutional holder of ATHE is Point72 Asset Management, L.P. with $453K in shares.

Are institutions buying or selling ATHE?

This quarter, 2 institutions opened new positions in ATHE and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.